Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Business
  • Published:

Drug firms back-pedal on direct advertising

Nature volume 436, pages 910–911 (2005)Cite this article

The pharmaceutical industry is taking a long, hard look at how it promotes its products to the public. Colin Macilwain reports.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Related links

Related links

Related links in Nature Research

How to avoid another 'Vioxx'

Painkiller in the dock

Related external links

www.phrma.org

www.citizen.org

www.levitra.com

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drug firms back-pedal on direct advertising. Nature 436, 910–911 (2005). https://doi.org/10.1038/436910a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/436910a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing